UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant

JAMA : the journal of the American Medical Association, 2023-03, Vol.329 (9), p.745

2023

Volltextzugriff (PDF)

Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and fludarabine conditioning

Journal of clinical oncology, 2014-11, Vol.32 (31), p.3497-3505

2014

Volltextzugriff (PDF)

Organ sparing of linac‐based targeted marrow irradiation over total body irradiation

Journal of applied clinical medical physics, 2019-11, Vol.20 (11), p.69-79

2019

Volltextzugriff (PDF)

Incidence and natural history of pure red cell aplasia in major ABO‐mismatched haematopoietic cell transplantation

British journal of haematology, 2013-03, Vol.160 (6), p.798-805

2013

Volltextzugriff (PDF)

Mesenchymal stem cells in ex vivo cord blood expansion

Best practice & research. Clinical haematology, 2011-03, Vol.24 (1), p.83-92

2011

Volltextzugriff (PDF)

Assessment of Pretreatment and Posttreatment Evolution of Neurofilament Light Chain Levels in Patients Who Develop Immune Effector Cell-Associated Neurotoxicity Syndrome

JAMA oncology, 2022-11, Vol.8 (11), p.1652

2022

Volltextzugriff (PDF)

Promises and challenges of a decentralized CAR T-cell manufacturing model

Frontiers in transplantation, 2023-09, Vol.2, p.1238535

2023

Volltextzugriff (PDF)

Dual institution experience of nodal marginal zone lymphoma reveals excellent long‐term outcomes in the rituximab era

British journal of haematology, 2016-10, Vol.175 (2), p.275-280

2016

Volltextzugriff (PDF)

Dual institution experience of extranodal marginal zone lymphoma reveals excellent long‐term outcomes

British journal of haematology, 2016-05, Vol.173 (3), p.404-412

2016

Volltextzugriff (PDF)

Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia

Bone marrow transplantation (Basingstoke), 2024-10

2024

Volltextzugriff (PDF)

Measurable residual FLT3 tyrosine kinase domain mutations before allogeneic transplant for acute myeloid leukemia

Bone marrow transplantation (Basingstoke), 2024-10

2024

Volltextzugriff (PDF)

Prophylaxis of Graft-Versus-Host Disease in Unrelated Donor Transplantation With Pentostatin, Tacrolimus, and Mini-Methotrexate: A Phase I/II Controlled, Adaptively Randomized Study

Journal of clinical oncology, 2011-01, Vol.29 (3), p.294-302

2011

Volltextzugriff (PDF)

Randomized phase II trial comparing two dose levels of thymoglobulin in patients undergoing unrelated donor hematopoietic cell transplant

Leukemia & lymphoma, 2012-05, Vol.53 (5), p.915-919

2012

Volltextzugriff (PDF)

Alternative Donor Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia

Seminars in hematology, 2015-07, Vol.52 (3), p.232-242

2015

Volltextzugriff (PDF)

Flow cytometry of DNMT1 as a biomarker of hypomethylating therapies

Cytometry. Part B, Clinical cytometry, 2024-01, Vol.106 (1), p.11-24

2024

Volltextzugriff (PDF)

Interleukin-2 and granulocyte–macrophage–colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer

International journal of hematology, 2009-12, Vol.90 (5), p.627-634

2009

Volltextzugriff (PDF)

Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab era

Hematology (Luxembourg), 2017-08, Vol.22 (7), p.405-411

2017

Volltextzugriff (PDF)

Adherence of stem cell transplant recipients receiving glucocorticoid therapy to an exercise-based rehabilitation program

Supportive care in cancer, 2012-10, Vol.20 (10), p.2391-2398

2012

Volltextzugriff (PDF)

Low rate of infusional toxicity after expanded cord blood transplantation

Cytotherapy (Oxford, England), 2014-08, Vol.16 (8), p.1153-1157

2014

Volltextzugriff (PDF)

Infections in 100 cord blood transplantations: spectrum of early and late posttransplant infections in adult and pediatric patients 1996-2005

Medicine (Baltimore), 2007-11, Vol.86 (6), p.324-333

2007

Volltextzugriff (PDF)

Donor leukocyte infusions in recurrent Hodgkin lymphoma following allogeneic stem cell transplant: 10-year experience at the M. D. Anderson Cancer Center

Leukemia & lymphoma, 2012-06, Vol.53 (6), p.1239-1241

2012

Volltextzugriff (PDF)

Reduced-Intensity Hematopoietic Cell Transplantation for Patients with Primary Myelofibrosis: A Cohort Analysis from the Center for International Blood and Marrow Transplant Research

Biology of blood and marrow transplantation, 2014-01, Vol.20 (1), p.89-97

2014

Volltextzugriff (PDF)

1 – 25 von 847

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(689)
Mit Volltextzugriff
(750)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant

Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and fludarabine conditioning

Organ sparing of linac‐based targeted marrow irradiation over total body irradiation

Incidence and natural history of pure red cell aplasia in major ABO‐mismatched haematopoietic cell transplantation

Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia

Mesenchymal stem cells in ex vivo cord blood expansion

Assessment of Pretreatment and Posttreatment Evolution of Neurofilament Light Chain Levels in Patients Who Develop Immune Effector Cell-Associated Neurotoxicity Syndrome

Promises and challenges of a decentralized CAR T-cell manufacturing model

Dual institution experience of nodal marginal zone lymphoma reveals excellent long‐term outcomes in the rituximab era

Dual institution experience of extranodal marginal zone lymphoma reveals excellent long‐term outcomes

Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors

Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia

Measurable residual FLT3 tyrosine kinase domain mutations before allogeneic transplant for acute myeloid leukemia

Prophylaxis of Graft-Versus-Host Disease in Unrelated Donor Transplantation With Pentostatin, Tacrolimus, and Mini-Methotrexate: A Phase I/II Controlled, Adaptively Randomized Study

Randomized phase II trial comparing two dose levels of thymoglobulin in patients undergoing unrelated donor hematopoietic cell transplant

Alternative Donor Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia

Flow cytometry of DNMT1 as a biomarker of hypomethylating therapies

Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide

Interleukin-2 and granulocyte–macrophage–colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer

Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab era

Adherence of stem cell transplant recipients receiving glucocorticoid therapy to an exercise-based rehabilitation program

Low rate of infusional toxicity after expanded cord blood transplantation

Infections in 100 cord blood transplantations: spectrum of early and late posttransplant infections in adult and pediatric patients 1996-2005

Donor leukocyte infusions in recurrent Hodgkin lymphoma following allogeneic stem cell transplant: 10-year experience at the M. D. Anderson Cancer Center

Reduced-Intensity Hematopoietic Cell Transplantation for Patients with Primary Myelofibrosis: A Cohort Analysis from the Center for International Blood and Marrow Transplant Research

Suchergebnisse filtern